Berman Capital Advisors’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CCM
GCM
RIM
KCM
Berman Capital Advisors's LMAT Position: Q3 2021 in Review
Berman Capital Advisors held its LeMaitre Vascular (LMAT) position steady in Q3 2021 at 177 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #1224.
Berman Capital Advisors first reported a position in LMAT in Q2 2020 and has held it in 6 quarters since. The position peaked at $10K in Q2 2021. 195 funds tracked by Wall St. Rank hold LMAT as of Q3 2021.
- Berman Capital Advisors held 177 shares of LeMaitre Vascular worth $9K as of Q3 2021.
- Berman Capital Advisors left its LeMaitre Vascular share count unchanged in Q3 2021.
- LeMaitre Vascular made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1224 holding.
- Berman Capital Advisors first reported a position in LeMaitre Vascular in Q2 2020 and has held it in 6 quarters since.
- Berman Capital Advisors's LeMaitre Vascular position peaked at $10K in Q2 2021.
- 195 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2021.
Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.